K212427

Substantially Equivalent

cobas Cdiff nucleic acid test for use on the cobas Liat System

Applicant: Roche Molecular Systems, Inc.
Product code: OZN
Advisory panel: Microbiology
Date received: 2021-08-04
Decision date: 2021-10-20
Decision: Substantially Equivalent
Clearance type: Special
Location: Pleasanton, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.